Biomarker Studies in Acute Ischemic Stroke
C Péter - 2019 - pea.lib.pte.hu
Stroke is defined by WHO as the clinical syndrome of rapid onset of focal (or global, as in
subarachnoid haemorrhage) cerebral deficits lasting more than 24 hours or leading to …
subarachnoid haemorrhage) cerebral deficits lasting more than 24 hours or leading to …
[PDF][PDF] Novel biomarkers in the era of modern stroke management
S Dóra - 2023 - pea.lib.pte.hu
Stroke was defined by the World Health Organization (WHO) in 1970, as rapidly developing
clinical signs of focal (or global) cerebral deficits, with symptoms lasting 24 hours or longer …
clinical signs of focal (or global) cerebral deficits, with symptoms lasting 24 hours or longer …
[PDF][PDF] BIOMARKERS IN ACUTE STROKE DIAGNOSIS: A SYSTEMATIC REVIEW PER BIOMARKER GROUP.
J Joye, S Hachimi-Idrissi, Z Mejiev, C Seroen… - 2020 - libstore.ugent.be
Stroke is defined as a “neurological deficit attributed to an acute focal injury of the central
nervous system by a vascular cause”(2). Several types of stroke exist, depending on their …
nervous system by a vascular cause”(2). Several types of stroke exist, depending on their …
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function
N Lüneburg, RA von Holten, RF Töpper… - Clinical …, 2012 - portlandpress.com
Methylarginines have been shown to interfere with NO (nitric oxide) formation by inhibiting
NOS (NO synthase)–ADMA (asymmetric dimethylarginine) and cellular l-arginine uptake …
NOS (NO synthase)–ADMA (asymmetric dimethylarginine) and cellular l-arginine uptake …
[PDF][PDF] L-Arginine pathway metabolites predict 6 months outcome after acute ischemic stroke
P Csecsei, L Nagy, S Keki, L Szapary, Z Illes… - Int J …, 2018 - researchgate.net
Background: Increased levels of asymmetric dimethylarginine (ADMA) and symmetric
dimethylarginine (SDMA) are associated with endothelial dysfunction. Here, we analyzed …
dimethylarginine (SDMA) are associated with endothelial dysfunction. Here, we analyzed …
The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome
T Molnar, G Pusch, V Papp, G Feher, L Szapary… - Journal of Stroke and …, 2014 - Elsevier
Background Endothelial dysfunction is associated with increased levels of asymmetric
dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) resulting in a decreased …
dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) resulting in a decreased …
Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B
P Dassan, G Keir, MM Brown - Cerebrovascular Diseases, 2009 - karger.com
Abstract Background and Purpose: Serum S100B has been widely studied as a biomarker in
acute ischaemic stroke. The main objective of this review was to appraise the published …
acute ischaemic stroke. The main objective of this review was to appraise the published …
Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen …
EC Jauch, C Lindsell, J Broderick, SC Fagan, BC Tilley… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—Biochemical markers of acute neuronal injury may aid in the
diagnosis and management of acute ischemic stroke. Serum samples from the National …
diagnosis and management of acute ischemic stroke. Serum samples from the National …
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
F Schulze, AM Carter, E Schwedhelm, R Ajjan, R Maas… - Atherosclerosis, 2010 - Elsevier
OBJECTIVE: Methylarginines have been shown to interfere with nitric oxide (NO) formation
by inhibiting NO synthase (asymmetric dimethylarginine, ADMA, and monomethylarginine …
by inhibiting NO synthase (asymmetric dimethylarginine, ADMA, and monomethylarginine …
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment
AK Saenger, RH Christenson - Clinical chemistry, 2010 - academic.oup.com
Background: Stroke is a devastating condition encompassing a wide range of
pathophysiological entities that include thrombosis, hemorrhage, and embolism. Current …
pathophysiological entities that include thrombosis, hemorrhage, and embolism. Current …